YMI..$1.68 I anticipate that this drop will be short-term. INCY has trumped for now because focus is on their approval. All eyes will be on YMI at ASH for their Phase II data release. That event should generate more interest in the stock again.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.